Modern therapeutics are facing severe challenge against the rapid, ever-emerging frightening threat of multi-drug resistance (MDR) bacterial pathogens and failed to cope up with the morbidity and mortality associated with it 1 . According to World Health Organization (WHO), Methicillin-resistant Staphylococcus aureus (MRSA) infections increases the mortality rate of patients by 64% as compared to infections caused by the non-resistant forms 2 . The drug development pipeline has not kept pace with the ever increasing need of efficient novel antibiotics. Due to uncertainty in the path to market and profitability, majority of the pharmaceutical companies have abandoned the antibiotic development program 3 . Antibiotic tolerance phenomenon shown by the persister cell population adds further burden to the current antibiotic crisis. This subpopulation of phenotypically inactive variants of regular bacteria arises mainly as a response to stress through gene regulation cascades (toxin/antitoxin module systems) 4 . The activity of traditional antibiotics (e.g., aminoglycosides, beta lactams, and fluoroquinolones) is restricted to only actively growing cells, whereas the metabolically inactive persister escapes the antibiotic action. Persister involvement in recalcitrance of chronic infections like tuberculosis and other biofilm associated infections were previously reported 5 . Superbugs that are resistant and tolerant to antibiotics are considered as a global epidemic and further deterioration will lead to the end of antibiotic era. Besides antimicrobial stewardship, novel therapeutic strategies and approaches are need of the hour to combat this consequential far-reaching problem 6, 7 . In this regard, we are following an alternative, accelerated and cost effective approach to impair the bacterial resistance and restore the efficacy of old antibiotics. Though development of nanoantibiotics against microbial pathogens 15, 16 . Combination of antibiotics with gold nanoparticles can restores its ability to destroy the bacteria that have acquired resistance towards them. The reason behind enhanced antibacterial activity was hypothesized as follows; (a) increase in the concentration of antibacterial at the site of antibiotic-bacterium interaction, (b) multivalent presentation of antibiotics, and (c) dysfunction of the bacterial efflux pump 17 . Gold nanoclusters (AUNCs) are attaining great attention in biomedical applications in last few years due to their unique characteristics including quantum mechanical behavior, excellent stability, high fluorescence intensity and good water solubility. Being ultra-small in size, AUNCs are explored as drug delivery vehicles that provide an interface for intense interactions with bacterial cellular and subcellular organelles 18 . Method development for AUNCs synthesis has been explored with special attention towards exploitation of biological protein molecules as reducing and stabilizing agent in 'one pot' synthesis process of AUNCs 19 . The amino, carboxyl and thiol groups of proteins play the crucial role in the reduction and stabilization of AUNCs preventing the super atoms from aggregation 20 . Protein-mediated synthesis of AUNCs has been reported using Human Serum Albumin, Bovine Serum Albumin, transferrin, trypsin, apoferritin, horseradish peroxidase and lysozyme 21 . Lysozyme (1,4-β-N-acetylmuramidase) is a relatively small enzyme (14,307 Da mass) which is a part of the innate immune system and plays an important role in the prevention of bacterial infections by both muramidase dependent and independent (non-enzymatic membrane perturbing) mechanisms of action 22 . It is comprising of two domains and a cleft in the protein center which acts as the active site. The secondary structure of each domain differs significantly with one domain being mainly helical and the other is β-sheet in structure 21 . Diabetes related chronic wounds including diabetic foot ulcers, pressure ulcers and venous leg ulcers are serious worldwide problem. Around 15% of diabetic patients develop lower extremity ulcers and 14-24% of them eventually undergo amputation 23 . Superficial infections and subsequent development of persistent biofilm of diabetic wounds (DW) hinder the normal phases of wound healing (hemostasis, inflammation, proliferation and remodeling). Due to patient compliance and recurrent use of antibiotics in the treatment of chronic diabetic wound infections leads to the development of bacterial resistance (MRSA, Vancomycin resistant S. aureus, etc.,) and further worsens the condition. Persister cell population of biofilm with antimicrobial tolerance obstructs the wound sterilization process and resulted in rapid regrowth of recalcitrant biofilms even after vigorous antibiotic treatment. Planktonic persister cells are reported to be less susceptible to antibiotics than static persister resides in biofilms. To regress the tolerant state of persister cells, several approaches have been attempted including the use of fatty acid signaling molecule cis-2-decenoic acid (cis-DA). In combination of antibiotics, it exhibited significant decrease in the persister cell population of Escherichia coli and Pseudomonas aeruginosa through escalation in their metabolic status without promoting their active growth 24 . In this present study, we evaluate the antibacterial effect of lysozyme capped gold nanoclusters (AUNC-L) functionalized with Amp (AUNC-L-Amp) on cis-DA pretreated MRSA persister. Further systemic MRSA infections and its associated complications resulted in high morbidity and mortality which demands prompted clinical attention. Community or hospital acquired multi-resistance MRSA (mrMRSA) infections can leads to irreversible damage. The prevalence of drug resistance strains is ever increasing, and hence treatment options (Vancomycin, Linezolid, etc.,) are getting limited to treat these chronic conditions.
The present study was aimed to investigate the antibacterial activity of AUNC-L-Amp against bacterial pathogens including MRSA clinical isolates in both metabolically active and inactive forms. We further confirm the activity of prepared nanohybrid against superficial and systemic MRSA infections in in vivo models. We hypothesized that functionalization of broad spectrum β-lactam antibiotic (Amp) with AUNC-L could restore its activity against MRSA and enhances the efficacy against non-resistant pathogens.
Results
Characterization of AUNC-L and AUNC-L-Amp. In this study, we have synthesized lysozyme capped gold nanoclusters (AUNC-L) which were confirmed by the presence of characteristic absorption peak of gold nanoclusters at 350 nm as shown in Fig. 1(a) 9,25 . The absorption peak of free ampicillin (Amp) was observed at 264 nm as shown in Fig. 1a . The absorption peaks obtained from AUNC-L-Amp, i.e., after the conjugation between free Amp and AUNC-L observed at 343 nm (inset Fig. 1a) . The peak at 278 nm is due to presence of lysozyme protein and the observed oscillation near the absorption peak of protein (green curve) confirms the successful conjugation of ampicillin on AUNC-L surfaces. The inset in Fig. 1a shows the zoomed images of AUNC-L and AUNC-L-Amp absorption peaks at elevated concentrations.
Transmission electron microscopy (TEM) analysis provides details about size and morphology of AUNC-L-Amp (Fig. 2) . Solid, spherical and ultra-small sized nanoclusters with the diameter ranging from (1-5 nm) were recorded for AUNC-L-Amp (Fig. 2b) . From the size distribution histogram (Fig. 2c) 26 . The steady state fluorescence study reveals that AUNC-L displays fluorescence emission at ≈407 nm against excited wavelength of 350 nm 25 . Whereas, for the conjugated system (AUNC-L-Amp) the fluorescence emission was observed at ≈420 nm against excitation wavelength of 350 nm Fig. 1d .
Infrared spectroscopy (IR) is one of the most convenient and efficient methods for characterizing the lysozyme conformational changes 27 . Lysozyme's amide-I (1700-1600 cm ) bands are the most prominent vibrational bands of its backbone. Amide-I region is most sensitive region and changes in conformation leads to changes in its secondary structures which is visible within the IR range of 1700-1600 cm −1 . In this study, a total of 16 peaks were assigned for both AUNC-L and AUNC-L-Amp (Fig. 1b, Fig. S1 & Table. S1). Peaks were assigned based on the beta sheet, beta turn, anti-parallel beta sheet, intra and inter-molecular beta strand, alpha helix, and random coil conformation 28, 29 . XRD spectrum Fig. 1c from AUNC-L shows a peak at 2θ ≈ 38.25° which corresponds to (111) crystal plane of fcc gold nanostructures. Diffraction peaks of Amp imply its poly crystalline nature 30, 31 . AUNC-L-Amp showed the characteristic peak of gold nanostructures (2θ≈38.25°) and Amp whereas the peak positions of Amp were modified which confirms the conjugation 17 . Surface-enhanced Raman spectroscopy (SERS) detects vibrational changes take place into the molecular level and determines the conformational changes occur in protein secondary structures 32 . The band at 930 cm −1 regions was assigned as C-C stretching of α-helix structure of lysozyme which was shifted to 935 cm −1 after nanoclusters formation and further shifted to 937 cm −1 on conjugation with ) were also observed in Raman spectra of AUNC-L-Amp which confirms the successful conjugation of Amp on AUNC-L (Fig. 1e ) 34 .
Biocompatibility of AUNC-L and AUNC-L-Amp.
Hemocompatibility. Hemolytic potential has been considered as a crucial parameter for biocompatibility evaluation of various blood-contacting biomedical materials. Hemolysis refers to the disturbance of RBC membrane integrity which results in hemoglobin release from RBC. In this present study, RBCs were exposed to different concentrations of the AUNC-L-Amp (0.01, 0.1 & 1 mg/ml) for 10 min, 1 h, 6 h, 12 h and 24 h (Fig. 3A) . AUNC-L-Amp at 0.01 & 0.1 mg/ml concentrations exhibited negligible hemolysis even after 24 h of incubation. However, at the tested highest concentration (1 mg/ml), the RBCs started to lyse from 1 h, reaching 1.6% hemolysis at 24 h which is in the permeable limit (5%) 35 . Cytocompatibility. To evaluate the cytocompatibility, MTT assay was performed. After 24 h of incubation with AUNC-L-Amp (up to 250 µg/ml) L929 cells exhibited a considerably higher viability (80.7%) compared to Free-Amp (78.4%) whereas bare AUNC-L exhibited the highest viability (86.2%) towards the tested cell lines (Fig. S2) . A majority of gold (I) and gold (III) compounds reported to exhibit varying degrees of toxicity towards mammalian cells 36 . In this present study, we found that AUNC-L-Amp was biocompatible towards mammalian cells and it reduces the toxicity of the drug candidates upon conjugation. were cultured up to stationary phase and treated with 20 μg/mL (10× MIC) gentamicin for 4 h 37 . Even after the treatment, the concentration (~10 10 CFU/ml) of MRSA population in stationary phase was not decreased (Fig. S3 ). The gentamicin-tolerant cells were further treated for additional 4 h with 10× MIC of gentamicin, vancomycin and ciprofloxacin to determine the tolerance of MRSA1 and MRSA2 towards other antibiotics. After 4 h of treatment, none of the antibiotic decreases the viability of the gentamicin-tolerant cells (Fig. S3) . These results suggested that all of the stationary phase population of MRSA1 and MRSA2 are in a persistent state, which is in agreement with previous reports 37, 38 .
In vitro anti-bacterial activity of Free-Amp, AUNC-L and AUNC-L-Amp. Antibacterial assay results demonstrated a significant enhancement (50-89% fold increase) in antibacterial activity of AUNC-L-Amp compared to Free-Amp in terms of zone of inhibition against 9 nonresistant bacterial pathogens ( Table. S2 ). Fascinatingly, Amp loading on AUNC-L enables its activity against 10 MRSA clinical isolates, where Free-Amp and AUNC-L did not exhibit considerable activity (Table. S3 ). MIC/MBC values exhibited by AUNC-L-Amp against the tested nonresistant bacterial pathogens were significantly lower than that of Free-Amp (Table. S4 ), whereas Free-Amp functionalization on AUNC-L (AUNC-L-Amp) retrieves the antibacterial activity of Amp against 10 MRSA clinical isolates (Table. S5 ). MRSA growth was not inhibited up to 5 mg/ml concentration of Free-Amp. For anti-MRSA activity studies, vancomycin was kept as standard which shows variable zone of inhibition (33-51 mm) and MIC/MBC values (0.5-2 µg/ml) against the tested MRSA strains. The AUNC-L-Amp retarded the biofilm formation by 95%, 95%, 92% & 88% respectively for the tested MRSA1, MRSA2, MRSA3 & MRSA4 strains where, there is no considerable inhibition of biofilm formation was observed in the case of Free-Amp (Table. S6 ). Since MRSA1 & 2 were found to be more susceptible to AUNC-L-Amp so these two strains were continued for further evaluations. AUNC-L-Amp, exhibited intensified killing rate against MRSA1 & 2at different time points (4   th   , 8 th & 12 th hour) whereas, Free-Amp obstructed the bacterial growth up to the 4 th hour (Fig. 4A) . In vitro assay results were also supported by FE-SEM analysis of MRSA1; where treatment with AUNC-L and Free-Amp did not exhibit an alteration in the bacterial morphology. On contrary to this, AUNC-L-Amp treatment destructed MRSA cellular structures ( Fig. 4B-E) . Confocal laser scanning microscopy analysis (CLSM) revealed the efficient penetration of AUNC-L-Amp and AUNC-L into the MRSA cytosol. Treatment of AUNC-L failed to kill the MRSA, whereas significant death was recorded in AUNC-L-Amp treated group (Fig. S4) . SYTOX Green membrane permeability assay for MRSA persister. Membrane permeabilization through direct or indirect means of cell damage is the main mode of action for several potent antibiotics such as HT61, lysostaphin and nisin 39 . As intact cell envelope is crucial for vitality of both actively dividing cells and persister, we assumed that cell wall penetrating nanopaticulate system can be an effective means for drug delivery against MRSA persister. In order to evaluate AUNC-L-Amp's potential in membrane permeabilization mediated killing of MRSA persister, reporter dye (SYTOX green) based assay was performed. Bacterial cells with permeabilized membranes can uptake the SYTOX Green and binding of same to DNA shows >500-fold signal enhancement 40 . As expected, AUNC-L-Amp induced substantial membrane permeabilization as measured up to 4 h (at definite time intervals), whereas the Free-Amp failed to do so in tested MRSA persister (Fig. 5A) .
Effect of AUNC-L-Amp on Cis-DA exposed MRSA persister. Recent reports suggested that cis-DA exposure mediated awakening of persister of Pseudomonas aeruginosa and Escherichia coli increases their susceptibility towards the co-administered antibiotics with a substantial decrease in viability to the point of eradication 24 . In this study, we evaluated free Amp and AUNC-L-Amp's ability to kill MRSA persister in presence of cis-DA (310 nM) for a period of 4 h. A significant (P < 0.001) decline in persister cell viability was observed for AUNC-L-Amp as compared to Free Amp treatment (Fig. 5B ). These findings demonstrate that Cis-DA alters the metabolic status of MRSA and increase its susceptibility towards AUNC-L-Amp. (Fig. 6A) . The AUNC-L-Amp system demonstrated clearance of MRSA from vital organs like kidney and spleen, which resulted in increased survival rate. Further, the survival rate at day 7 post-MRSA infection was significantly higher in the AUNC-L-Amp treated group compared with the Free-Amp, AUNC-L and PBS treated groups (Fig. 6B) .
Effect of AUNC-L-

Effect of topical application of AUNC-L-Amp on wound healing in MRSA infected diabetic wounds.
Significant (p ≤ 0.05) reduction in MRSA load in terms of CFU count (2.6 to 7.5 logs) at different time intervals (3 rd , 7 th , 14 th & 21 st day) was observed in AUNC-L-Amp treated MRSA infected DW compared to PBS treatment. Free-Amp treatment failed to reduce the MRSA load on DW (Fig. S5) . Pronounced wound healing was observed in AUNC-L-Amp treated animals which were comparable to non-infected DW. Mortality was recorded in PBS & Free-Amp treated animals during 10 to 17 days of post-infection (Fig. 7) . Further, AUNC-L-Amp treatment normalized the abnormal inflammatory cytokines (IL-1β & TNF-α) whereas no difference was observed in other treatment groups (Figs S6 and S7) . Histopathology results of wound area on 21 st day further strengthen the claim as the dermal ultra-structure was better organized with prominent epithelialization and distinct acanthotic maturing sub-epidermis in AUNC-L-Amp treated animals. In the case of PBS (on the 13 th day) and Free-Amp (on the 17 th day) treated animals showed complete disruptions along with inflammatory cell infiltrate (Fig. 8) . 
Discussion and Conclusion
Conventional antibiotics with typical mechanism of actions are gradually getting resisted by MRSA at a faster pace. In this regard, researchers are pursuing development of innovative facile strategies to formulate accelerated, cost effective, alternative approaches for the effective treatment of resistant bacterial infections. The dearth in treatment options encourages the efficacy restoration or enhancement of inefficacious or limited efficacious antibiotics through integrating the same with nanoscalic entities. In this regard the present study demonstrates the functionalization of widely used β-lactam antibiotic Amp (as a model drug) on AUNC-L to combat MRSA and other non-resistant bacterial pathogens. Lysozyme is an antibacterial enzyme which acting as reducing and capping agent in the synthesis of AUNC-L. Further Amp molecule was subsequently surface functionalized on AUNC-L; predominantly through thioether moiety mediated partial covalent interaction (Au-S-Amp and Au-N-Amp bonds) and electrostatic interaction between negatively charged Amp and positively charged AUNC-L 41 . Being ultra-small in size, AUNCs are like small drug molecules which enabling their homogeneous controlled interaction with Amp which in turn leads to a consistent release of both the agents. Interaction of Amp with AUNC-L resulted in a shift (peak at around ≈ 343 nm) in UV spectra which confirms the successful conjugation (Fig. 1a) . Further, shift in the fluorescent emission spectrum of AUNC-L-Amp clearly indicates the conjugation of Amp on the surface of AUNC-L (Fig. 1d) , which is also supported by previous reports 29 . Due to higher surface area to volume ratio the fabricated nanoclusters allows higher Amp loading efficiency on its surface (72%). FT-IR spectra depict the conformational changes in the lysozyme secondary structures after the formation of AUNC-L and AUNC-L-Amp. The IR spectra of AUNC-L-Amp reveal prominent peak shift in beta-turn, alpha helix, random coil, inter-molecular strand and side chain vibration which indicate successful conjugation of Amp on AUNC-L surface (Fig. 1b) . The synthesis and conjugation were also confirmed from the results of DLS, TEM (Fig. 2), XRD (Fig. 1c), SERS (Fig. 1e) and zeta potential analysis. The AUNC-L-Amp demonstrates excellent biocompatibility towards human RBC and mouse fibroblast cells (L929) (Fig. 3 and Fig. S2 ). Interactions of mammalian cells with biomaterial are mostly mediated by the electrostatic interaction between positively charged biomaterials and negatively charged cell membrane 42 . In this study, the interaction between positively charged AUNC-L-Amp and mammalian cells does not result in substantial membrane disintegration. Surface chemistry, shape, size, surface activity, chemical composition, and solubility of nanomaterials play a crucial role in its biocompatibility and endocytosis-exocytosis patterns [42] [43] [44] [45] . Lysozyme functionalization on gold nanoclusters introduce biocompatible functionalities with formation of more stable protein corona in biological fluids. Nanoclusters undergoes pinocytosis which are less cytotoxic than nanoparticles, as the bigger particles get wrapped in the process of endocytosis and causes increased cellular uptake and subsequent toxicity 46 . In this context, previous studies suggested that gold nanoparticles of less than 3 nm are found to be non-toxic in in vivo systems with a faster rate of exocytosis 47 . Unlike widely evaluated antibacterial silver nanomaterials, AUNCs does not involves in reactive oxygen species (ROS) mediated cell death 9 . ROS independent mode of action of AUNCs partly explains the minimum cytotoxicity of AUNC-L and AUNC-L-Amp. Previous reports suggested that lysozyme capped gold nanoclusters possess antibacterial activity against pan-drug-resistant Acinetobacter baumannii and vancomycin-resistant Enterococcus; but its activity against MRSA is not known 48 . Functionalization of Amp on AUNC-L restores its efficacy against MRSA clinical isolates and increases the therapeutic index against nonresistant bacterial pathogens. Nanoclusters possess superior antibacterial action due to porin protein channels mediated pronounced permeation into the cell 19 . Owing to have thicker cell walls, gram + Ve bacteria are less susceptible to bactericidal nanomaterials. In this study, lysozyme coating on AUNC renders its activity even against gram + Ve bacteria. Lysozyme denature the peptidoglycan through hydrolyzes of β (1 → 4) linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues. Unlike Gram − Ve cell wall, higher amount of peptidoglycan and absence of outer membrane in Gram + Ve cell wall, render them more susceptible towards lysozyme mediated hydrolysis. But, lysozyme resistant phenomena is common in Gram + Ve Staphylococcus species and O-acetyltransferase OatA gene was found as the major determinant for the same 49 . In this study, AUNC-L exhibited considerable antibacterial activity against nonresistant gram + Ve bacterial pathogens. On the other hand, both AUNC-L and Free-Amp fails to exhibit antibacterial activity against MRSA. Amp activity has been restored towards MRSA clinical isolates upon conjugation with AUNC-L (Tables S2-S7) & (Fig. 4) . Amp functionalization on AUNC-L increases the concentration of Amp at the site of antibiotic action which in turn facilitates multivalent binding of Amp on bacterial cell wall and blocks the efflux pump 11 . Lysozyme directed multivalent binding, and Amp mediated subsequent cell wall disruptions resulted in profound permeation of AUNC-L-Amp into the bacterial cell. Amp irreversibly inhibits transpeptidase and prevents third and final stage of bacterial cell wall synthesis and binary fission 50 . Though gold is generally regarded as biologically inert, ions released from AUNCs inside the bacterial cell has been reported to inhibit ATPase activities. This in turn destabilizes membrane potential, permeability, respiration, and binding affinity of ribosome subunit to t-RNA. Further it effects the functions of sulfur containing proteins (Fe-S protein) and phosphorous containing compounds (DNA) 51 . AUNC-L-Amp capable of over counters the β-lactamase due to increased ratio of Amp at the site of action. AUNC-L-Amp complex withstand MRSA resistance even after multiple exposures (15 times) of sub-inhibitory concentrations (Table S7) . Antibacterial study results suggest that both lysozyme and Amp retains their activity which is in agreement with previous reports 52 . The AUNC-L-Amp is also capable of killing antibiotic tolerant MRSA persister population upon awakening through cis-2-decenoic acid (cis-DA) exposure. SYTOX Green membrane permeability and persister killing kinetics assay results demonstrated significant decrease in the MRSA persister cell population (Fig. 5) . Multivalent presentation, lysozyme-mediated cell wall lysis, increased permeation of AUNC-L-Amp and efflux pump dysfunction disrupts the bacterial persister cells 53 . AUNC-L-Amp eradicated MRSA infections from diabetic wound which accounting for pronounced and quicker wound healing (Fig. 7) . The nanohybrid crosses the dermal epithelium easily and reduces the MRSA burden (Fig. S5) , which attributes to decreased levels of inflammatory cytokines (Figs S6 and S7) . Presence of lysosome in nanohybrid also helps in wound healing process through the cationic influence on the cell membrane of keratinocytes and developing acidic pH 54 . Further, AUNC-L-Amp also kills systemic MRSA and increased the life span of infected mice (Fig. 6) . Ultra-small size of AUNC-L-Amp allows a slower and sustained release of Au species unlike the burst release behavior of Au ions from bigger nanoparticles. This phenomenon protects the mammalian cells from unwanted damages through rapid excretion of nanoclusters from the body 9 . In this study, we have developed a coherent broad spectrum antibacterial hybrid through Amp functionalization on lysozyme capped AUNCs. This system reverts MRSA resistance and significantly increased the anti-bacterial efficacy against non-resistant bacterial pathogenic strains. A significant decrease in the MRSA load on kidney and spleen was achieved through AUNC-L-Amp intraperitoneal administration, which results in improved survival rate of infected animals (Fig. 6) . Topical application of AUNC-L-Amp also eradicates MRSA infection on diabetic wounds and resulted in acceleration of the healing process (Fig. 8) . We conjecture that, MRSA resistance reversion and enhanced antibacterial activity of AUNC-L-Amp is due to; (i) increase in the Amp concentration at the site of action (ii) multivalent presentation and increased permeation of Amp (iii) lysozyme-mediated cell wall lysis (iv) bacterial efflux pump dysfunction (v) gold ion mediated destabilization (Fig. S8) . 
Experimental section
Synthesis of lysozyme capped AUNCs (AUNC-L) and Ampicillin loading on AUNC-L.
A 15 mg/ ml freshly prepared lysozyme solution was obtained by dissolving desired amount of lyophilized lysozyme powder in Milli-Q water. The lysozyme solution was stirred at the speed of 500 rpm and maintained at 4 °C. Further, an aqueous solution of HAuCl 4 was slowly introduced in the protein solution drop by drop and maintained the final concentration as 2 mM. The pH of the solution was maintained at ≈6.5 throughout the experiment. The stirring is continued until the color of the solution was changed to pale red color, which indicates the formation of lysozyme capped gold nanoclusters (AUNC-L). The solution was centrifuged at 4500 rpm for 5 min to segregate the large or agglomerated entities and the supernatant was filtered through 0.22 µm membrane. The resulting solution containing AUNC-L was subjected to freeze drying and mixed with Amp in ultra-pure water at 1:2 ratio respectively. The reaction mixture was stirred for 24 h under dark conditions at 4 °C. Further, the solution was centrifuged and washed with ultrapure water to remove the free drug, followed by lyophilization. The contents of Amp in supernatant was measured through UV−vis spectrophotometry to evaluate the Amp loading efficiency 
In vitro antibacterial activity evaluation. Zone of inhibition (ZOI), Minimum inhibitory concentration (MIC) and Minimum bactericidal concentration (MBC).
The ZOI experiment for Free Amp, AUNC-L and AUNC-L-Amp (25 µg/ml) was performed by agar disk diffusion method 55 . The enhancement in antibacterial activity of the nonresistant pathogenic bacteria in response to the treatment of AUNC-L-Amp was quantified by the following equation: (B − A)/A × 100, here A and B denotes to ZOI for Free-Amp and AUNC-L-Amp respectively.
Broth micro dilution method was employed to evaluate the MIC for Free-Amp, AUNC-L-Amp against the bacteria mentioned in ZOI section 7 . After 48 h of incubation, the wells with no bacterial growth on treatment with Free-Amp, AUNC-L-Amp were sub cultured on nutrient agar plates by 0.2 ml of inoculum to determine the MBC 56 . Vancomycin (25 µg/ml) was kept as negative control for these experiment. MRSA persister membrane permeability assay. MRSA persister membrane permeability evaluation was performed by SYTOX Green assay 57 .
Morphological characterization of bacteria. MRSA1 suspension containing 5 × 10 7 CFU/ml was incubated with AUNC-L & AUNC-L-Amp (16 µg/ml) for 12 h, centrifuged (4500 rpm) at 4 °C for 10 min and washed with sterile PBS. Bacteria with no treatment were considered as control (for FE-SEM only). After the treatment period, bacterial cells from all the treatment groups were fixed with 3% glutaraldehyde solution and preceded for FE-SEM and confocal microscopic analysis.
Activity against MRSA persister population. Persister isolation. To isolate persister cells, overnight cultures of MRSA1 and MRSA2 (cultured in tryptic soy broth at 37 °C) were treated with 10 × MIC (20 μg/mL) gentamicin for 4 h. Activation of the SOS response in the presence of gentamycin was exploited to isolate MRSA persister cells from planktonic population 24 .
Persister killing efficacy assays. Killing efficacy assays were performed following standardized protocol 55 . Concisely, persister cells were exposed to Free-Amp, and AUNC-L-Amp at a concentration of 16 μg/mL along with the fatty acid signaling molecule cis-DA. MRSA1 and MRSA2 persister cells were pelleted, resuspended in 50 mL of saline, and aliquots of 7 mL were subjected to one of the following treatments: Free-Amp (or) AUNC-L-Amp in combination with cis-DA (310 nM) in saline. Cultures were incubated for 24 h at 37 °C with shaking (220 rpm). Persister cell viability was determined at definite time interval (0, 10, 20, 30, 40, 50, 60, 120, 180, 240 min) by both spectrophotometrically and CFU count method.
In vivo experiments. Animals. To conduct the in vivo experiments swiss albino mice and wistar rats were Efficacy of AUNC-L-Amp in a systemic MRSA murine infection model. MRSA1 culture was grown in nutrient broth for 12 h and diluted to an OD 600 of 0.6 at 37 °C with subsequent shaking, centrifugation and washing in PBS. Intraperitoneal injection of MRSA1 of 3.9 × 10 6 CFU was given to Swiss albino male mice (n = 8; age: 4 weeks; weight: 22 ± 2 g). After 1 h of infection induction, the animals were treated with intraperitoneal injection of different treatments as follows-
• G-I: Animals with infection + PBS.
• G-II: Animals with infection + 25 mg/kg of Free-Amp.
• G-III: Animals with infection + 25 mg/kg of AUNC-L.
• G-IV: Animals with infection + 25 mg/kg of AUNC-L-Amp.
Post 23 h of drug treatment, 4 animals from each group were sacrificed, and the kidneys and spleens were harvested in a sterile condition, homogenized in PBS (pH: 7.4) and plated on nutrient agar for CFU determination. Drug treatments were continued every 24 h for remaining 4 animals up to 7 days to determine the survival rate.
Efficacy of AUNC-L-Amp in rat diabetic wound infection model. Male rats of Wistar strain weighing 200-220 g were selected for this study. Diabetes was induced to overnight fasted rats through single intraperitoneal injection of streptozotocin (STZ) at 55 mg/kg (dissolved in 0.1 M citrate buffer of pH 4.5). Diabetes was confirmed through measuring fasting blood glucose (FBG) levels three days post STZ injection. Animals having FBG levels > 250 mg/dl were selected and included in the study. After 4 days of diabetes induction, animals were anesthetized by intraperitoneal injection of ketamine and xylazine cocktail (80 & 10 mg/kg respectively) and wounds (1.5 cm in diameter) were created on the dorsal side with a surgical scalpel. The wounds were inoculated with MRSA1 (200 µl of 2 × 10 9 CFU/ml) culture and covered with sterile cotton gauge. After 3 days of incubation, wound scrapings were collected to measure the CFU load for confirming infection establishment and following drug treatment was administered from 4 th day and continued for 20 days. Grouping and drug treatment: (n = 6)
• G-I: Diabetic wounds with no infection and treated with PBS topically.
• G-II: Diabetic wounds with MRSA infection and treated with PBS topically.
• G-III: Diabetic wounds with MRSA infection and treated with Free-Amp topically at16 µg/ml.
• G-IV: Diabetic wounds with MRSA infection and treated with AUNC-L-Amp topically at16 µg/ml. th day for G-III) for histopathology examination. Slides were stained with hematoxylin and eosin to observe the skin pathology under the light microscope.
The detailed description of remaining experimental procedures has been given in supplementary information.
